These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18490861)

  • 1. Prostaglandin as a target molecule for pharmacotherapy of allergic inflammatory diseases.
    Nagai H
    Allergol Int; 2008 Sep; 57(3):187-96. PubMed ID: 18490861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.
    Honda T; Matsuoka T; Ueta M; Kabashima K; Miyachi Y; Narumiya S
    J Allergy Clin Immunol; 2009 Oct; 124(4):809-18.e2. PubMed ID: 19541354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prostaglandins in allergic lung inflammation and asthma.
    Claar D; Hartert TV; Peebles RS
    Expert Rev Respir Med; 2015 Feb; 9(1):55-72. PubMed ID: 25541289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2).
    Tajima T; Murata T; Aritake K; Urade Y; Hirai H; Nakamura M; Ozaki H; Hori M
    J Pharmacol Exp Ther; 2008 Aug; 326(2):493-501. PubMed ID: 18492946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3.
    Kunikata T; Yamane H; Segi E; Matsuoka T; Sugimoto Y; Tanaka S; Tanaka H; Nagai H; Ichikawa A; Narumiya S
    Nat Immunol; 2005 May; 6(5):524-31. PubMed ID: 15806106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation.
    Bain G; Lorrain DS; Stebbins KJ; Broadhead AR; Santini AM; Prodanovich P; Darlington J; King CD; Lee C; Baccei C; Stearns B; Troung Y; Hutchinson JH; Prasit P; Evans JF
    J Pharmacol Exp Ther; 2011 Jul; 338(1):290-301. PubMed ID: 21487069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases.
    Mitsumori S
    Curr Pharm Des; 2004; 10(28):3533-8. PubMed ID: 15579050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoids receptors signaling in different diseases/cancers progression.
    Yang Y; Tang LQ; Wei W
    J Recept Signal Transduct Res; 2013; 33(1):14-27. PubMed ID: 23327583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the development of anti-allergic drugs.
    Nagai H; Teramachi H; Tuchiya T
    Allergol Int; 2006 Mar; 55(1):35-42. PubMed ID: 17075284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice.
    Herrerias A; Torres R; Serra M; Marco A; Roca-Ferrer J; Picado C; de Mora F
    Int Arch Allergy Immunol; 2009; 149(4):323-32. PubMed ID: 19295236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins in the kidney: developments since Y2K.
    Nasrallah R; Clark J; Hébert RL
    Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
    Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
    Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoids in immunity: roles revealed by mice deficient in their receptors.
    Narumiya S
    Life Sci; 2003 Dec; 74(2-3):391-5. PubMed ID: 14607267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E₂ induced contraction of human intercostal arteries is mediated by the EP₃ receptor.
    Longrois D; Gomez I; Foudi N; Topal G; Dhaouadi M; Kotelevets L; Chastre E; Norel X
    Eur J Pharmacol; 2012 Apr; 681(1-3):55-9. PubMed ID: 22342278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery.
    Hung GH; Jones RL; Lam FF; Chan KM; Hidaka H; Suzuki M; Sasaki Y
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jun; 74(6):401-15. PubMed ID: 16737803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the role of prostaglandins in allergic lung inflammation: separating friends from foes, harder than you might think.
    Moore ML; Peebles RS
    J Allergy Clin Immunol; 2006 May; 117(5):1036-9. PubMed ID: 16675329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandin E and F receptor agonists in vivo on luteal function in ewes.
    Weems YS; Nett TM; Rispoli LA; Davis TL; Johnson DL; Uchima T; Raney A; Lennon E; Harbert T; Bowers G; Tsutahara N; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):67-72. PubMed ID: 20381634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2.2.1]heptane derivatives.
    Mitsumori S; Tsuri T; Honma T; Hiramatsu Y; Okada T; Hashizume H; Inagaki M; Arimura A; Yasui K; Asanuma F; Kishino J; Ohtani M
    J Med Chem; 2003 Jun; 46(12):2436-45. PubMed ID: 12773047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.